The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study

Post time 6 day(s) ago

journal：Journal of Gastroenterology and Hepatology

Authors：Qianjun Zhuang; Aijun Liao; Qingling He; Chengxia Liu; Changqing Zheng; Xing Li; Youli Liu; Bangmao Wang; Side Liu; Yan Zhang; Rong Lin; Huixin Chen; Min Deng; Yanping Tang; Chiyi He; Weijie Dai; Haitao Tang; Lei Gong; Liangping Li; Baohong Xu; Changqing Yang; Bingxi Zhou; Dongxing Su; Qinghong Guo; Bin Li; Yongjian Zhou; Xiaoyang Wang; Sujuan Fei; Huili Wu; Sichen Wei; Zhihong Peng; Jianning Wang; Yanqing Li; Hong Wang; Tianwei Deng; Shigang Ding; Fangfang Li; Minhu Chen; Yinglian Xiao

Published date：2024-4-

DOI：10.1111/jgh.16471

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.16471

Article link：http://dx.doi.org/10.1111/jgh.16471

Article Source：Wiley。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today